BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 2731167)

  • 1. In vivo DNA cross-linking by cyclophosphamide: comparison of human chronic lymphatic leukemia cells with mouse L1210 leukemia and normal bone marrow cells.
    DeNeve W; Valeriote F; Edelstein M; Everett C; Bischoff M
    Cancer Res; 1989 Jul; 49(13):3452-6. PubMed ID: 2731167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kinetics of DNA cross-linking in normal and neoplastic mouse tissues following treatment with cis-diamminedichloroplatinum(II) in vivo.
    Murray D; Jenkins WT; Meyn RE
    Cancer Res; 1985 Dec; 45(12 Pt 1):6446-52. PubMed ID: 4063992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction of N,N',N''-triethylenethiophosphoramide and N,N',N''-triethylenephosphoramide with cellular DNA.
    Cohen NA; Egorin MJ; Snyder SW; Ashar B; Wietharn BE; Pan SS; Ross DD; Hilton J
    Cancer Res; 1991 Aug; 51(16):4360-6. PubMed ID: 1714342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biophysical investigations on L1210 mouse leukemia cells treated with activated cyclophosphamide metabolites: determination of selective properties of DNA-interstrand and DNA-protein cross-linking mechanisms (alkaline elution and 31P-NMR-spectroscopy) and some aspects of the combination drug and radiotherapy.
    Ulmer W
    Strahlenther Onkol; 1990 Feb; 166(2):157-63. PubMed ID: 2315845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of WR2721 on DNA cross-linking by nitrogen mustard in normal mouse bone marrow and leukemia cells in vivo.
    DeNeve WJ; Everett CK; Suminski JE; Valeriote FA
    Cancer Res; 1988 Nov; 48(21):6002-5. PubMed ID: 2844397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the mechanism of action of busulfan with hepsulfam, a new antileukemic agent, in the L1210 cell line.
    Pacheco DY; Stratton NK; Gibson NW
    Cancer Res; 1989 Sep; 49(18):5108-10. PubMed ID: 2766282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interstrand DNA-DNA and DNA-protein cross-links by a new antitumor antibiotic, FK973, in L1210 cells.
    Masuda K; Nakamura T; Mizota T; Mori J; Shimomura K
    Cancer Res; 1988 Sep; 48(18):5172-7. PubMed ID: 3409243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interactions of mitomycin C with mammalian DNA detected by alkaline elution.
    Dorr RT; Bowden GT; Alberts DS; Liddil JD
    Cancer Res; 1985 Aug; 45(8):3510-6. PubMed ID: 3926301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of the bifunctional antitumor intercalator ditercalinium on DNA in mouse leukemia L1210 cells and DNA topoisomerase II.
    Markovits J; Pommier Y; Mattern MR; Esnault C; Roques BP; Le Pecq JB; Kohn KW
    Cancer Res; 1986 Nov; 46(11):5821-6. PubMed ID: 3019538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytotoxicity, DNA cross-linking, and single strand breaks induced by activated cyclophosphamide and acrolein in human leukemia cells.
    Crook TR; Souhami RL; McLean AE
    Cancer Res; 1986 Oct; 46(10):5029-34. PubMed ID: 3463409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New platinum, titanium, and ruthenium complexes with different patterns of DNA damage in rat ovarian tumor cells.
    Frühauf S; Zeller WJ
    Cancer Res; 1991 Jun; 51(11):2943-8. PubMed ID: 2032232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytotoxicity and DNA cross-linking activity of 4-sulfidocyclophosphamides in mouse leukemia cells in vitro.
    Erickson LC; Ramonas LM; Zaharko DS; Kohn KW
    Cancer Res; 1980 Nov; 40(11):4216-20. PubMed ID: 7471062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA-protein cross-linking and DNA interstrand cross-linking by haloethylnitrosoureas in L1210 cells.
    Ewig RA; Kohn KW
    Cancer Res; 1978 Oct; 38(10):3197-203. PubMed ID: 150940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chlorozotocin. Mechanism of reduced bone marrow toxicity in mice.
    Panasci LC; Green D; Schein PS
    J Clin Invest; 1979 Oct; 64(4):1103-11. PubMed ID: 158033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA damage and cytotoxicity in L1210 cells by ellipticine and a structural analogue, N-2-(diethylaminoethyl)-9-hydroxyellipticinium chloride.
    Djuric Z; Everett CK; Valeriote FA
    Cancer Res; 1992 Mar; 52(6):1515-9. PubMed ID: 1540960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of DNA interstrand cross-linking and strand breakage by 1,3-bis(2-chloroethyl)-1-nitrosourea in polyamine-depleted and control human adenocarcinoma cells.
    Seidenfeld J; Barnes D; Block AL; Erickson LC
    Cancer Res; 1987 Sep; 47(17):4538-43. PubMed ID: 3113720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of DNA damage by methylmelamines and formaldehyde.
    Ross WE; McMillan DR; Ross CF
    J Natl Cancer Inst; 1981 Jul; 67(1):217-21. PubMed ID: 6788992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene-specific formation and repair of DNA monoadducts and interstrand cross-links after therapeutic exposure to nitrogen mustards.
    Souliotis VL; Dimopoulos MA; Sfikakis PP
    Clin Cancer Res; 2003 Oct; 9(12):4465-74. PubMed ID: 14555520
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms of action of a novel macromolecular antitumor antibiotic, SN-07, on mouse leukemia L1210 cells in culture.
    Yajima N; Miyata N; Kawanishi G; Katayama S; Tsukagoshi S
    Jpn J Cancer Res; 1987 Oct; 78(10):1121-7. PubMed ID: 3119545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alkylator resistance in human B lymphoid cell lines: (1). Melphalan accumulation, cytotoxicity, interstrand-DNA-crosslinks, cell cycle analysis, and glutathione content in the melphalan-sensitive B-lymphocytic cell line (WIL2) and in the melphalan-resistant B-CLL cell line (WSU-CLL).
    Pu Q; Bianchi P; Bezwoda WR
    Anticancer Res; 2000; 20(4):2561-8. PubMed ID: 10953327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.